

Oligo Synthesis : CEPs
Prices quoted are for single packs only. For multiples of the same product please request a quote. Some of Glen"sproductsarehazardousandmay be subject to additional shipping charges. Full product information is available onGlen Research"s website.
dmf-isodG-CE Phosphoramidite
dmf-isodG-CE Phosphoramidite
Glen Research
Catalogue No. | Description | Pack Size | Price | Qty |
|
---|---|---|---|---|---|
10-1078-02 | dmf-isodG-CE Phosphoramidite | 0.25g | £284.00£269.80Offer until : 31-Mar-2021Offer Code : GLEN5View Offer | Quantity | Add to Order |
10-1078-90 | dmf-isodG-CE Phosphoramidite | 100µmoles | £132.00£125.40Offer until : 31-Mar-2021Offer Code : GLEN5View Offer | Quantity | Add to Order |
Related products
dmf-isodG-CE Phosphoramidite
dmf-isodG-CE Phosphoramidite
Glen Research
dmf-isodG-CE Phosphoramidite |
Catalog Number: 10-1078-xx
Description: dmf-isodG-CE Phosphoramidite
5"-Dimethoxytrityl-O2-diphenylcarbamoyl-N6-dimethylaminomethylidene-2"-deoxyisoGuanosine,3"-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite | ||
Formula: C56H62N9O8P | M.W.: 1020.13 | F.W.: 329.21 |
Diluent: Anhydrous Acetonitrile |
Coupling: No changes needed from standard method recommended by synthesizer manufacturer.Mild Deblocking Mix Required. Use 2.5-3% DCA instead of TCA |
Deprotection: No changes needed from standard method recommended by synthesizer manufacturer. |
Storage: Freezer storage, -10 to -30°C, dry |
Stability in Solution: 2-3 days |
Please Note: These products are supplied under license from EraGen Biosciences, Inc. US Patents 5,432,272, 6,001,983, 6,037,120, and 6,140,496. |
DUPLEX EFFECTS
The design of primers is frequently complicated by the degeneracy of the genetic code. Three strategies are now available to confront this problem. In the first, a mixed base addition (N) is used to form the degenerate site. This approach is best if the number of degenerate sites is small. A second option is the use of 2’-deoxyInosine or 2’-deoxyNebularine which exhibit low, but unequal, hydrogen bonding to the other four bases. The third option is the use of a universal nucleoside. In this strategy, the base analog does not hybridize significantly to the other four bases and makes up some of the duplex destabilization by acting as an intercalating agent. 3-Nitropyrrole 2’-deoxynucleoside (M) is the first example of a set of universal bases. Subsequently, 5-nitroindole was determined to be an effective universal base and to be superior to 3-nitropyrrole, based on duplex melting experiments.
The modified bases designated P and K show considerable promise as degenerate bases. The pyrimidine derivative P, when introduced into oligonucleotides, base pairs with either A or G, while the purine derivative K base pairs with either C or T. A dP dK mix also can serve as a mixed base with much less degeneracy than dA dC dG dT (N).
Unnatural base pairs display unique abilities in duplex DNA and in nucleic acid and protein biosyntheses. A standard Watson and Crick base pair is formed between iso-C and iso-G, but the hydrogen bonding pattern is quite different from the natural base pairs A-T and C-G. (The 5-methyl analogue was chosen as the synthetic target due to the reported instability of 2’-deoxyisocytidine caused by deamination during oligonucleotide synthesis or deprotection.)
The unnatural base pair between 7-(2-thienyl)-imidazo[4,5-b]pyridine (Ds) and pyrrole-2-carbaldehyde (Pa) is formed by specific hydrophobic shape complementation. The shape of the Ds-Pa pair is different from those of the natural A-T and G-C pairs, but the Ds-Pa pair works together with the natural pairs in in vitro replication and transcription. Pa also functions as a template base for incorporating another unnatural base, 2-amino-6-(2-thienyl)purine (s), into RNA. The s base also acts as a unique fluorescent base analog in DNA and RNA fragments. dDss is strongly fluorescent and is useful as a fluorescent tag for DNA detection. dDss also forms a base pair with dPa. Biotin PaTP can be site-specifically incorporated into RNA, opposite dDs at a desired position in DNA templates, by T7 transcription. Similarly, the fluorescent s base can be site-specifically incorporated into RNA opposite dPa in DNA templates.
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
dmf-isodG-CE Phosphoramidite
dmf-isodG-CE Phosphoramidite
Glen Research
Material Safety Data Sheet
Glen Report 20.1: Technical Brief - New application of 5-Me-iso-dC and iso-dG
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
dmf-isodG-CE Phosphoramidite
dmf-isodG-CE Phosphoramidite
Glen Research
A standard Watson and Crick base pair is formed between iso-C and iso-G, but the hydrogen bonding pattern is quite different from the natural base pairs A-T and C-G. (The 5-methyl analogue was chosen as the synthetic target due to the reported instability of 2’-deoxyisocytidine caused by deamination during oligonucleotide synthesis or deprotection.)
EXTINCTION DATA
Item | Nucleoside | λMax-1 | Emax-1 | λMax-2 | Emax-2 | E260 |
(nm) | (ml/µmole) | nm | (ml/µmole) | (ml/µmole) | ||
10-1078 | iso-dG | 292 | 4.6 |
DILUTION/COUPLING DATA
The table below shows pack size data and, for solutions, dilutions and approximate couplings based on normal priming procedures. Please link formore detailed usage informationwith the various synthesizers.
ABI 392/394 | |||||||||
Cat.No. | PackSize | Grams/Pack | 0.1M Dil.(mL) | LV40 | LV200 | 40nm | 0.2µm | 1µm | 10µm |
Approximate Number of Additions | |||||||||
10-1078-02 | 0.25grams | .25grams | 2.45 | 68.33 | 41 | 25.63 | 18.64 | 13.67 | 3.42 |
10-1078-90 | 100µmoles | .102grams | 1 | 20 | 12 | 7.5 | 5.45 | 4 | 1 |
Expedite | |||||||||
Cat.No. | PackSize | Grams/Pack | Dilution(mL) | Molarity | 50nm | 0.2µm | 1µm | 15µm | |
Approximate Number of Additions | |||||||||
10-1078-02 | 0.25grams | .25grams | 3.66 | .07 | 66.8 | 41.75 | 30.36 | 4.18 | |
10-1078-90 | 100µmoles | .102grams | 1.5 | .07 | 23.6 | 14.75 | 10.73 | 1.48 | |
Beckman | |||||||||
Cat.No. | PackSize | Grams/Pack | Dilution(mL) | Molarity | 30nm | 200nm | 1000nm | ||
Approximate Number of Additions | |||||||||
10-1078-02 | 0.25grams | .25grams | 3.66 | .07 | 68.4 | 42.75 | 31.09 | ||
10-1078-90 | 100µmoles | .102grams | 1.5 | .07 | 25.2 | 15.75 | 11.45 |
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
AthensResearch&Technology公司位于美国乔治亚州雅典市,从1986年以来一直致力于纯化高纯度,高活性的人类蛋白质和开发这些蛋白的多克隆抗血清。我们的常规产品包括丝氨酸蛋白酶、蛋白酶抑制剂、中性粒细胞酶、载脂蛋白、脂蛋白,血小板蛋白、转铁蛋白、免疫球蛋白等。二十年多年来,世界各地的研究人员都在使用我们公司的产品。在炎症、冠状动脉疾病、自身免疫性疾病、癌症、老年痴呆症等等研究的主要科学出版物中都能看到引用我们公司的产品。我们提供优质,可靠的产品和出色的客户服务。我们期待着您的业务。如果需要定制研究服务,AthensResearch&Technology公司能够根据您的项目要求提供无与伦比的试剂。
公司主要产品:一、凝血因子相关系列产品:包括多款从人血浆、血小板中分离纯化的凝血因子相关蛋白。二、酶及抑制剂系列产品:包括多款从人血浆、红细胞分离纯化的a-抗糜蛋白酶、a1/2抗胰蛋白酶、抗凝血酶、C1酯酶抑制因子、Calpain-1等酶及其抑制剂产品。三、免疫球蛋白系列产品:包括多款从人血浆、骨髓瘤、初乳以及狗和小鼠血浆中分离纯化的免疫球蛋白产品。四、脂蛋白及载脂蛋白系列产品:包括包括多款从人血浆中分离纯化的载脂蛋白及脂蛋白(高密度、中等密度、低密度、极低密度脂蛋白)产品。五、低内毒素蛋白系列产品:包括多款适宜于细胞培养的低内毒素脂蛋白、免疫球蛋白及转铁蛋白产品。六、乳蛋白系列产品:包括从人乳中分离纯化的乳白蛋白、乳铁传递蛋白及分泌型免疫球蛋白A。七、中性粒细胞源蛋白系列产品:包括多款纯化分离自人中性粒细胞的Azurocidin 、CathepsinG及Lactoferrin等蛋白产品。八、血小板相关系列产品:包括纯化分离自人血小板的血小板因子4及凝血酶致敏蛋白。九、转铁蛋白及脱铁转铁蛋白(APOTRANSFERRINS)系列产品:包括多款纯化分离自人、大小鼠、狗及食蟹猴血浆中的转铁蛋白/脱铁转铁蛋白,可应用于细胞或组织培养。十、抗体系列产品:包括多款兔、大鼠、羊源的多克隆抗体产品。
ebiomall.com







